Nuclear Medicine and Biology
Volume 35, Issue 2 , Pages 213-218 , February 2008

Evaluation of radioiodinated (2S,αS)-2-(α-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart

  • Yasushi Kiyono

      Affiliations

    • Biomedical Imaging Research Center, University of Fukui, Fukui 910-1193, Japan
    • Radioisotopes Research Laboratory, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan
    • Corresponding Author InformationCorresponding author. Biomedical Imaging Research Center, University of Fukui, 23-3, Matsuokashimoaizuki, Eiheiji, Yoshida, Fukui 910-1193, Japan. Tel.: +81 776 61 8420; fax: +81 776 61 8170.
    • ,
  • Taku Sugita

      Affiliations

    • Department of Pathofunctional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan
    • ,
  • Masashi Ueda

      Affiliations

    • Radioisotopes Research Laboratory, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan
    • ,
  • Hidekazu Kawashima

      Affiliations

    • Department of Nuclear Medicine and Diagnostic Imaging, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan
    • ,
  • Naoki Kanegawa

      Affiliations

    • Department of Pathofunctional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan
    • ,
  • Yuji Kuge

      Affiliations

    • Department of Pathofunctional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan
    • ,
  • Yasuhisa Fujibayashi

      Affiliations

    • Biomedical Imaging Research Center, University of Fukui, Fukui 910-1193, Japan
    • ,
  • Hideo Saji

      Affiliations

    • Department of Pathofunctional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan

Received 5 September 2007 ,Revised 23 November 2007 ,Accepted 23 November 2007.

References 

  1. Mandela P, Ordway GA. The norepinephrine transporter and its regulation. J Neurochem. 2006;97:310–333
  2. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH, et al. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol. 2001;33:461–472
  3. Bohm M, La Rosee K, Schwinger RH, Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol. 1995;25:146–153
  4. Fukumitsu N, Suzuki M, Fukuda T, Kiyono Y, Kajiyama S, Saji H. Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism. Nucl Med Biol. 2006;33:37–42
  5. Kiyono Y, Iida Y, Kawashima H, Ogawa M, Tamaki N, Nishimura H, et al. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. Eur J Nucl Med Mol Imaging. 2002;29:999–1005
  6. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342:541–549
  7. Ungerer M, Chlistalla A, Richardt G. Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart. Circ Res. 1996;78:1037–1043
  8. Keller NR, Diedrich A, Appalsamy M, Tuntrakool S, Lonce S, Finney C, et al. Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity. Circulation. 2004;110:1191–1196
  9. Munch G, Rosport K, Bultmann A, Baumgartner C, Li Z, Laacke L, et al. Cardiac overexpression of the norepinephrine transporter uptake-1 results in marked improvement of heart failure. Circ Res. 2005;97:928–936
  10. Schroeder C, Birkenfeld AL, Mayer AF, Tank J, Diedrich A, Luft FC, et al. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope. J Am Coll Cardiol. 2006;48:516–522
  11. Carrio I. Cardiac neurotransmission imaging. J Nucl Med. 2001;42:1062–1076
  12. Langer O, Halldin C. PET and SPET tracers for mapping the cardiac nervous system. Eur J Nucl Med Mol Imaging. 2002;29:416–434
  13. Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging. 2007;34:939–950
  14. Kiyono Y, Kanegawa N, Kawashima H, Fujiwara H, Iida Y, Nishimura H, et al. A new norepinephrine transporter imaging agent for cardiac sympathetic nervous function imaging: radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine. Nucl Med Biol. 2003;30:697–706
  15. Kiyono Y, Kanegawa N, Kawashima H, Kitamura Y, Iida Y, Saji H. Evaluation of radioiodinated (R)-N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine as a ligand for brain norepinephrine transporter imaging. Nucl Med Biol. 2004;31:147–153
  16. Kanegawa N, Kiyono Y, Kimura H, Sugita T, Kajiyama S, Kawashima H, et al. Synthesis and evaluation of radioiodinated (S,S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter. Eur J Nucl Med Mol Imaging. 2006;33:639–647
  17. Raisman R, Sette M, Pimoule C, Briley M, Langer SZ. High-affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline. Eur J Pharmacol. 1982;78:345–351
  18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
  19. Haka MS, Kilbourn MR. Synthesis and regional mouse brain distribution of [11C]nisoxetine, a norepinephrine uptake inhibitor. Int J Rad Appl Instrum B. 1989;16:771–774
  20. Nakamura H, Edo K, Hishinuma T, Takahashi T, Ido T, Mizugaki M. Synthesis of 11C-labeled imipramine and its biodistribution in mice: a potential tracer for positron emission tomography. Chem Pharm Bull (Tokyo). 1989;37:3376–3379
  21. Tseng YT, Padbury JF. Expression of a pulmonary endothelial norepinephrine transporter. J Neural Transm. 1998;105:1187–1191
  22. Fowler JS, Gallagher BM, MacGregor RR, Wolf AP. Carbon-11 labeled aliphatic amines in lung uptake and metabolism studies: potential for dynamic measurements in vivo. J Pharmacol Exp Ther. 1976;198:133–145
  23. Moretti JL, Zini R, Morin D, Joulin Y, Desplanches G, Caillat-Vigneron N, et al. Interactions of phenylalkylamines with human lung membrane and microsome preparation. Nucl Med Commun. 1987;8:115–120
  24. Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennett LR. A noninvasive procedure for in vivo assay of a lung amine endothelial receptor. J Nucl Med. 1985;26:1302–1307
  25. Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J. 1993;126:390–398

PII: S0969-8051(07)00298-3

doi: 10.1016/j.nucmedbio.2007.11.006

Nuclear Medicine and Biology
Volume 35, Issue 2 , Pages 213-218 , February 2008

Article Tools

* Image Usage & Resolution